Serum thyroglobulin measurements in differentiated thyroid cancer

Biomedicine and Pharmacotherapy

Volumn 54, Issue 6, 2000, Pages 330-333

  Girelli, M E ^a,b   De Vido, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Institute of Medical Semeiotics   (Italy)

Author keywords

Assay; Differentiated thyroid cancer; Serum thyroglobin; Thyroid hormone suppression therapy

Indexed keywords

THYROGLOBULIN; THYROTROPIN;

BENIGN TUMOR; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY;

EID: 0033855856     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)80058-X     Document Type: Conference Paper

References (20)

1. 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy)
2. The comparative value of serum thyroglobulin and iodine- 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
3. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: Comparison of its value in patients with or without normal residual tissue
4. The value of serum thyroglobulin measurements in clinical practice
5. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
6. Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppressive therapy: Study on 429 patients
7. Clinical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus levels after hormone withdrawal and total body scan: Results in 291 patients with thyroid cancer
8. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer
9. European interlaboratory comparison of serum thyroglobulin measurement
10. Current status and performance goals for serum thyroglobulin assays
11. Thyroid autoanti-bodies in thyroid cancer: Incidence and relationship with tumor outcome
12. Clinical meaning of circulating anti-thyroglobulin antibodies in differentiated thyroid cancer: A prospective study
13. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays
14. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
15. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
16. 131I therapy for elevated thyroglobulin levels
17. Evaluation and treatment of persistent thyroglobulin in patients with well-differentiated thyroid cancer
18. Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow-up of differentiated thyroid carcinoma
19. Dosage de la thyroglobuline serique apres lobectomie thyroidienne totale unilaterale pour cancer thyroidien differencie
20. Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy